News

What are the most important psychiatric advancements and insights from 2025? Share with us!

Read discussion of bromism, with case studies and background on bromine.

ChatGPT's rapid rise sparks debate on its profound impact, blending remarkable capabilities with alarming risks, as society grapples with AI's future.

Explore the importance of gratitude in psychiatry, addressing challenges, stigma, and the pursuit of mental health improvement in communities.

Explore updates from November 2025, including AI, drug updates, and more.

Check out the pipeline updates from November!

"When the spade sinks into gravelly ground: My father, digging. I look down..."

Tiffani Bell-Washington, MD, MPH shares insights on compassionate lifestyle changes for adolescents facing obesity, emphasizing collaboration and individualized care strategies.

In this CME article, explore effective strategies for assessing and preventing suicide risk in patients with bipolar disorder, including interdisciplinary approaches and evidence-based interventions.

Lithium significantly reduces suicidal ideation and attempts in bipolar and major depressive disorder patients, enhancing long-term treatment outcomes.

Otsuka Pharmaceutical submits a new drug application for centanafadine for treatment of ADHD, showing significant efficacy across all age groups.

Hormonal fluctuations significantly influence ADHD symptoms in women, highlighting the need for tailored treatments and further research in this area.

Explore the complexities of insomnia treatment, highlighting the limited role of melatonin and the effectiveness of cognitive behavioral therapy for better sleep.

Frank Clark, MD, reflects on the upcoming holiday through poetry.

Explore the evolving landscape of mental health care as chatbots and human therapists collaborate to enhance accessibility, safety, and emotional connection.

Women are experiencing ongoing trauma and sexual abuse, highlighting the need for psychiatric support and societal change.

Explore the latest insights on lecanemab and low-dose lithium for Alzheimer disease prevention and treatment, weighing benefits and risks effectively.

Discover the latest insights from Southern Florida Psychiatry Conference on stuttering, its neurological basis, and innovative treatment approaches to improve quality of life for those affected.

Vagus nerve stimulation offers a promising solution for treatment-resistant depression, showcasing significant long-term efficacy and durability in patients.

Experts at the Southern Florida Psychiatry Conference emphasize the importance of screening for postpartum depression, highlighting effective treatments and support strategies for new mothers' mental health.

Experts discuss the advantages of long-acting injectables in schizophrenia treatment, highlighting improved adherence, reduced relapse risk, and better patient outcomes.

Explore the complexities of treatment-resistant depression and the vital role of advanced practice providers in enhancing patient care and outcomes.

Take a look at the long-term effects of stimulant medications on ADHD, specifically tolerance and its implications for treatment efficacy.

Digital therapeutics revolutionize health care by enhancing patient outcomes through technology and offering scalable, evidence-based treatments for various conditions.

Lipocine's LPCN 1154 shows promise in treating postpartum depression, with a favorable safety profile and potential for rapid relief.

Explore the unique benefits of Ingrezza, a VMAT2 inhibitor for tardive dyskinesia, and how it compares to other treatment options.

Discover how objective testing transforms ADHD diagnosis and treatment, enhancing accuracy and accessibility for adults in hybrid care settings.

At-home transcranial magnetic stimulation offers a safe, effective way to treat depression, enhancing access and reducing reliance on medications.